A

Astoria Biologica

1 employees

Astoria Biologica is developing novel therapies for multiple sclerosis

Basic info

Industry

biotechnology research

Funding rounds raised

A

Astoria Biologica raised undisclosed on December 1, 2022

Investors: Curie.Bio

FAQ